Compound Profile: Beligas Pharma Dostinex-Lite 0.
Dostinex-Lite 0.5mg is a pharmaceutical-grade cabergoline formulation manufactured by Beligas Pharma for in-vitro laboratory research applications. Cabergoline is a synthetic ergot alkaloid derivative classified as a selective dopamine D2 receptor agonist, extensively studied for its potent prolactin-inhibitory properties in endocrine research protocols. This compound demonstrates high binding affinity for dopamine receptors in the anterior pituitary, making it valuable for investigating lactotroph cell function and hormonal feedback mechanisms. Researchers at Stroid UK Shop utilize cabergoline formulations to examine prolactin suppression kinetics and dopaminergic pathway modulation in controlled laboratory environments.
Laboratory Research Applications
Scientists investigate cabergoline for its unique pharmacological profile in prolactin regulation studies, examining its mechanism of action on dopamine D2 receptors within lactotroph cells. Research protocols focus on analyzing the compound’s ability to suppress prolactin secretion through direct pituitary stimulation, with studies demonstrating prolonged inhibitory effects lasting several days in experimental models. The compound’s selectivity for dopamine receptors makes it particularly valuable for researchers studying hyperprolactinemia models and investigating the relationship between dopaminergic signaling and reproductive hormone regulation. Laboratory investigations also examine cabergoline’s potential applications in post-cycle therapy research, where prolactin normalization is a primary research objective. Additional studies explore its effects on growth hormone secretion patterns and its interaction with other pituitary hormones in complex endocrine research models, often conducted alongside SARM investigations and peptide research protocols.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Cabergoline |
| Concentration | 0.5mg per tablet |
| CAS Number | 81409-90-7 |
| Molecular Formula | C₂₆H₃₇N₅O₂ |
| Molecular Weight | 451.604 g/mol |
| Manufacturer | Beligas Pharma |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
Dostinex-Lite 0.5mg is manufactured by Beligas Pharma exclusively for in-vitro research purposes and is not intended for human consumption, clinical use, or therapeutic applications. This product is supplied to qualified researchers and institutions for laboratory investigations into prolactin regulation, dopamine receptor function, and endocrine system studies. Purchasers must ensure compliance with all applicable research regulations and institutional guidelines governing the use of research chemicals in laboratory environments.

